{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:40:48Z","timestamp":1759743648000,"version":"build-2065373602"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","award":["106859","106859","106859"],"award-info":[{"award-number":["106859","106859","106859"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1120129","GNT1120129","GNT1140465"],"award-info":[{"award-number":["GNT1120129","GNT1120129","GNT1140465"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["2011853"],"award-info":[{"award-number":["2011853"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Baker Foundation, Australia","award":["Baker Fellowship"],"award-info":[{"award-number":["Baker Fellowship"]}]},{"name":"NSW Health, Australia","award":["Cardiovascular Research Capacity Program - Research Leadership Grant"],"award-info":[{"award-number":["Cardiovascular Research Capacity Program - Research Leadership Grant"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Cardiovasc Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Atrial fibrillation (AF), often accompanied by atrial fibrosis, is challenging to diagnose sub-clinically and reverse once established. Molecular imaging targeting excess atrial collagen may enable earlier detection of atrial fibrosis and its associated arrhythmias. We used the collagen I-binding peptide EP-3533 and our novel \u2018T-peptide\u2019 targeting matrix metalloproteinases-2-digested collagen IV to image interstitial atrial fibrosis, AF and heart failure (HF) that develop in the double transgenic mouse model dnPI3K-Mst1 (termed \u2018AF\u2009+\u2009HF\u2019). Ex vivo and in vivo imaging were performed using near-infrared scans and positron emission tomography (PET) with probes conjugated to Cyanine5.5 and copper-64, respectively. Both tracers significantly accumulated in fibrotic atria compared to non-transgenic controls, with specific T-peptide uptake relative to a mutated \u2018S-peptide\u2019. Pharmacokinetic profiling demonstrated good tracer plasma stability and fast renal clearance. These results highlight the potential of collagen-targeted peptide tracers, particularly the disease stage-sensitive T-peptide, to improve diagnosis and monitoring of atrial fibrosis and AF.<\/jats:p>","DOI":"10.1038\/s44325-025-00086-2","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:13:06Z","timestamp":1759741986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Collagen-targeted tracers for molecular imaging of atrial fibrosis and sensitive detection of atrial fibrillation"],"prefix":"10.1038","volume":"2","author":[{"given":"Be\u2019eri","family":"Niego","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph E.","family":"Hagemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Jupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asif","family":"Noor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thirimadura V. H.","family":"Mendis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi Ching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie R.","family":"McMullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Alt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"86_CR1","unstructured":"Australian Institute of Health and Welfare. Cardiovascular disease (AIHW, Canberra, 2020)."},{"key":"86_CR2","doi-asserted-by":"publisher","unstructured":"Gallagher, C. et al. Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013. Heart, https:\/\/doi.org\/10.1136\/heartjnl-2018-314471 (2019).","DOI":"10.1136\/heartjnl-2018-314471"},{"key":"86_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/STROKEAHA.119.025554","volume":"51","author":"M Alberts","year":"2020","unstructured":"Alberts, M. et al. Risks of stroke and mortality in atrial fibrillation patients treated with rivaroxaban and warfarin. Stroke 51, 549\u2013555 (2020).","journal-title":"Stroke"},{"key":"86_CR4","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jacc.2007.09.064","volume":"51","author":"B Burstein","year":"2008","unstructured":"Burstein, B. & Nattel, S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J. Am. Coll. Cardiol. 51, 802\u2013809 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"86_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.pbiomolbio.2012.07.011","volume":"110","author":"S Kumar","year":"2012","unstructured":"Kumar, S. et al. Atrial remodeling in varying clinical substrates within beating human hearts: relevance to atrial fibrillation. Prog. Biophys. Mol. Biol. 110, 278\u2013294 (2012).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"86_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21911-y","volume":"8","author":"Q Wang","year":"2018","unstructured":"Wang, Q. et al. Human epicardial adipose tissue cTGF expression is an independent risk factor for atrial fibrillation and highly associated with atrial fibrosis. Sci. Rep. 8, 3585 (2018).","journal-title":"Sci. Rep."},{"key":"86_CR7","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1016\/j.jacc.2021.04.012","volume":"77","author":"YC Chen","year":"2021","unstructured":"Chen, Y. C., Voskoboinik, A., Gerche, A., Marwick, T. H. & McMullen, J. R. Prevention of pathological atrial remodeling and atrial fibrillation: JACC state-of-the-art review. J. Am. Coll. Cardiol. 77, 2846\u20132864 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"86_CR8","doi-asserted-by":"publisher","unstructured":"Li, C. Y., Zhang, J. R., Hu, W. N. & Li, S. N. Atrial fibrosis underlying atrial fibrillation (Review). Int. J. Mol. Med. 47, https:\/\/doi.org\/10.3892\/ijmm.2020.4842 (2021).","DOI":"10.3892\/ijmm.2020.4842"},{"key":"86_CR9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jama.2013.1363","volume":"309","author":"A Gulati","year":"2013","unstructured":"Gulati, A. et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309, 896\u2013908 (2013).","journal-title":"JAMA"},{"key":"86_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1536\/ihj.37.483","volume":"37","author":"K Nogami","year":"1996","unstructured":"Nogami, K. et al. Extracellular matrix components in dilated cardiomyopathy. Immunohistochemical study of endomyocardial biopsy specimens. Jpn Heart J. 37, 483\u2013494 (1996).","journal-title":"Jpn Heart J."},{"key":"86_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1536\/ihj.39.753","volume":"39","author":"T Watanabe","year":"1998","unstructured":"Watanabe, T. et al. Localization of type IV collagen alpha chain in the myocardium of dilated and hypertrophic cardiomyopathy. Jpn Heart J. 39, 753\u2013762 (1998).","journal-title":"Jpn Heart J."},{"key":"86_CR12","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.yjmcc.2008.07.007","volume":"45","author":"CL Chen","year":"2008","unstructured":"Chen, C. L. et al. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation. J. Mol. Cell Cardiol. 45, 742\u2013753 (2008).","journal-title":"J. Mol. Cell Cardiol."},{"key":"86_CR13","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cardiores.2005.08.023","volume":"69","author":"GY Wang","year":"2006","unstructured":"Wang, G. Y. et al. Cardiac transgenic matrix metalloproteinase-2 expression directly induces impaired contractility. Cardiovasc Res. 69, 688\u2013696 (2006).","journal-title":"Cardiovasc Res."},{"key":"86_CR14","doi-asserted-by":"publisher","unstructured":"Ezeani, M., Hagemeyer, C. E., Lal, S. & Niego, B. Molecular imaging of atrial myopathy: Towards early AF detection and non-invasive disease management. Trends Cardiovasc. Med. https:\/\/doi.org\/10.1016\/j.tcm.2020.12.002 (2020).","DOI":"10.1016\/j.tcm.2020.12.002"},{"key":"86_CR15","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jacc.2010.11.013","volume":"57","author":"N Mewton","year":"2011","unstructured":"Mewton, N., Liu, C. Y., Croisille, P., Bluemke, D. & Lima, J. A. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J. Am. Coll. Cardiol. 57, 891\u2013903 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"86_CR16","first-page":"329","volume":"29","author":"J Stirrat","year":"2013","unstructured":"Stirrat, J. & White, J. A. The prognostic role of late gadolinium enhancement magnetic resonance imaging in patients with cardiomyopathy. Can. J. Cardiol. 29, 329\u2013336 (2013).","journal-title":"Can. J. Cardiol."},{"key":"86_CR17","first-page":"H1","volume":"326","author":"YC Chen","year":"2024","unstructured":"Chen, Y. C. et al. Cardiovascular magnetic resonance imaging for sequential assessment of cardiac fibrosis in mice: technical advancements and reverse translation. Am. J. Physiol. Heart Circ. Physiol. 326, H1\u2013H24 (2024).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"86_CR18","doi-asserted-by":"publisher","first-page":"E403","DOI":"10.1016\/S0735-1097(13)60403-9","volume":"61","author":"JP Bois","year":"2013","unstructured":"Bois, J. P. et al. Left atrial delayed enhancement by MRI is not associated with occurrence or type of atrial fibrillation: a single-center experience. J. Am. Coll. Cardiol. 61, E403 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"86_CR19","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1001\/jama.2014.3","volume":"311","author":"NF Marrouche","year":"2014","unstructured":"Marrouche, N. F. et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. Jama 311, 498\u2013506 (2014).","journal-title":"Jama"},{"key":"86_CR20","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2353\/ajpath.2009.090126","volume":"175","author":"L Pretorius","year":"2009","unstructured":"Pretorius, L. et al. Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation. Am. J. Pathol. 175, 998\u20131009 (2009).","journal-title":"Am. J. Pathol."},{"key":"86_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6705","volume":"5","author":"G Sapra","year":"2014","unstructured":"Sapra, G. et al. The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice. Nat. Commun. 5, 5705 (2014).","journal-title":"Nat. Commun."},{"key":"86_CR22","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1158\/1541-7786.MCR-08-0538","volume":"7","author":"J Mueller","year":"2009","unstructured":"Mueller, J., Gaertner, F. C., Blechert, B., Janssen, K. P. & Essler, M. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo. Mol. Cancer Res. 7, 1078\u20131085 (2009).","journal-title":"Mol. Cancer Res."},{"key":"86_CR23","doi-asserted-by":"publisher","first-page":"8171","DOI":"10.1002\/anie.200700700","volume":"46","author":"P Caravan","year":"2007","unstructured":"Caravan, P. et al. Collagen-targeted MRI contrast agent for molecular imaging of fibrosis. Angew. Chem.46, 8171\u20138173 (2007).","journal-title":"Angew. Chem."},{"key":"86_CR24","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1148\/radiol.2473070975","volume":"247","author":"PA Helm","year":"2008","unstructured":"Helm, P. A. et al. Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent. Radiology 247, 788\u2013796 (2008).","journal-title":"Radiology"},{"key":"86_CR25","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1039\/C3DT52647J","volume":"43","author":"BM Paterson","year":"2014","unstructured":"Paterson, B. M. et al. PET imaging of tumours with a 64cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate. Dalton Trans. 43, 1386\u20131396 (2014).","journal-title":"Dalton Trans."},{"key":"86_CR26","doi-asserted-by":"publisher","first-page":"e022139","DOI":"10.1161\/JAHA.121.022139","volume":"10","author":"M Ezeani","year":"2021","unstructured":"Ezeani, M. et al. Collagen-targeted peptides for molecular imaging of diffuse cardiac fibrosis. J. Am. Heart Assoc. 10, e022139 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"86_CR27","doi-asserted-by":"publisher","first-page":"e230098","DOI":"10.1148\/ryct.230098","volume":"6","author":"B Niego","year":"2024","unstructured":"Niego, B. et al. Molecular imaging of diffuse cardiac fibrosis with a radiotracer that targets proteolyzed collagen IV. Radio. Cardiothorac. Imaging 6, e230098 (2024).","journal-title":"Radio. Cardiothorac. Imaging"},{"key":"86_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1161\/01.CIR.101.1.71","volume":"101","author":"X-J Du","year":"2000","unstructured":"Du, X.-J. et al. \u03b22-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis. Circulation 101, 71\u201377 (2000).","journal-title":"Circulation"},{"key":"86_CR29","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/j.1476-5381.2010.01043.x","volume":"162","author":"Q Xu","year":"2011","unstructured":"Xu, Q. et al. Myocardial oxidative stress contributes to transgenic \u03b2\u2082-adrenoceptor activation-induced cardiomyopathy and heart failure. Br. J. Pharm. 162, 1012\u20131028 (2011).","journal-title":"Br. J. Pharm."},{"key":"86_CR30","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jhep.2013.06.026","volume":"59","author":"BC Fuchs","year":"2013","unstructured":"Fuchs, B. C. et al. Molecular MRI of collagen to diagnose and stage liver fibrosis. J. Hepatol. 59, 992\u2013998 (2013).","journal-title":"J. Hepatol."},{"key":"86_CR31","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1165\/rcmb.2013-0039OC","volume":"49","author":"P Caravan","year":"2013","unstructured":"Caravan, P. et al. Molecular magnetic resonance imaging of pulmonary fibrosis in mice. Am. J. Respir. Cell Mol. Biol. 49, 1120\u20131126 (2013).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"86_CR32","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1042\/CS20240178","volume":"138","author":"YC Chen","year":"2024","unstructured":"Chen, Y. C. et al. Distinct functional and molecular profiles between physiological and pathological atrial enlargement offer potential new therapeutic opportunities for atrial fibrillation. Clin. Sci.138, 941\u2013962 (2024).","journal-title":"Clin. Sci."},{"key":"86_CR33","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jacc.2023.01.017","volume":"81","author":"M Alkhouli","year":"2023","unstructured":"Alkhouli, M. et al. Nonthrombogenic roles of the left atrial appendage: JACC review topic of the week. J. Am. Coll. Cardiol. 81, 1063\u20131075 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"key":"86_CR34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1161\/01.RES.5.4.357","volume":"5","author":"DE Oken","year":"1957","unstructured":"Oken, D. E. & Boucek, R. J. Quantitation of collagen in human myocardium. Circ. Res. 5, 357\u2013361 (1957).","journal-title":"Circ. Res."},{"key":"86_CR35","doi-asserted-by":"publisher","first-page":"e0129124","DOI":"10.1371\/journal.pone.0129124","volume":"10","author":"N Smorodinova","year":"2015","unstructured":"Smorodinova, N. et al. Bioptic study of left and right atrial interstitium in cardiac patients with and without atrial fibrillation: interatrial but not rhythm-based differences. PLoS One 10, e0129124 (2015).","journal-title":"PLoS One"},{"key":"86_CR36","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1096\/fj.201601209R","volume":"31","author":"T Fukuta","year":"2017","unstructured":"Fukuta, T. et al. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke. FASEB J. 31, 1879\u20131890 (2017).","journal-title":"FASEB J."}],"container-title":["npj Cardiovascular Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44325-025-00086-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44325-025-00086-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44325-025-00086-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:13:09Z","timestamp":1759741989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44325-025-00086-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86"],"URL":"https:\/\/doi.org\/10.1038\/s44325-025-00086-2","relation":{},"ISSN":["2948-2836"],"issn-type":[{"value":"2948-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.R.M. is an Associate Editor at npj Cardiovascular Health but was not involved in the journal\u2019s review of, or decisions related to, this manuscript. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}